Postoperative management of severe acute anemia in a Jehovah's Witness

Transfusion

Volumn 54, Issue 4, 2014, Pages 1153-1157

  De Araújo Azi, Liana Maria Tôrres ^a   Lopes, Fernando Muniz ^a   Garcia, Luis Vicente ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; DOPAMINE; ERYTHROPOIETIN; FOLIC ACID; HEMOGLOBIN; HEPARIN; IRON SALT; ISOFLURANE; KETAMINE; NORADRENALIN; PROPOFOL; RINGER LACTATE SOLUTION; SODIUM CHLORIDE; TRANEXAMIC ACID;

ACUTE DISEASE; ADULT; ANEMIA; ARTICLE; ARTIFICIAL VENTILATION; BLOOD PRESSURE; BLOOD TRANSFUSION; BRAIN INFECTION; CASE REPORT; CENTRAL VENOUS PRESSURE; CONTINUOUS INFUSION; CRYSTALLOID; DISEASE SEVERITY; EXTUBATION; FEMALE; FIBROSIS; HEMATOCRIT; HEMODILUTION; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPOTENSION; JEHOVAH'S WITNESS; KYPHOSIS; LORDOSIS; MEAN ARTERIAL PRESSURE; MEDULLA OBLONGATA; OSTEOTOMY; POSTOPERATIVE CARE; POSTOPERATIVE HEMORRHAGE; SCOLIOSIS; SINUS TACHYCARDIA; THROMBOCYTE COUNT; TISSUE PERFUSION; UNCONSCIOUSNESS;

ACUTE DISEASE; ADULT; ANEMIA; BLOOD TRANSFUSION; ERYTHROPOIETIN; FEMALE; HUMANS; JEHOVAH'S WITNESSES; POSTOPERATIVE HEMORRHAGE; RESPIRATION, ARTIFICIAL; SEVERITY OF ILLNESS INDEX; TREATMENT REFUSAL;

EID: 84898924498     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12424     Document Type: Article

References (28)

1. Gross JB,. Estimating allowable blood loss: corrected for dilution. Anesthesiology 1983; 58: 277-280.
2. Selby IR, Lerman J,. Anesthesia for Jehovah's Witnesses. Anaesthesia 1996; 51: 95-96.
3. Neff TA, Stocker R, Wight E, et al. Extreme intraoperative blood loss and hemodilution in a Jehovah's Witness: new aspects in postoperative management. Anesthesiology 1999; 91: 1949-1951.
4. Brimacombe J, Skippen P, Talbutt P,. Acute anemia to a haemoglobin of 14 g/L with survival. Anaesth Intensive Care 1991; 19: 581-583.
5. Howell PJ, Bamber PA,. Severe acute anaemia in a Jehovah's Witness. Anaesthesia 1987; 42: 44-48.
6. Dupuis JF, Nguyen DT,. Anesthetic management of the patient who refuses blood transfusions. Cancer Bull 1995; 47: 67-73.
7. Shander A, Rijhwani TS,. Acute normovolemic hemodilution. Transfusion 2004; 44: 26S-34S. (Pubitemid 39636416)
8. Goodnough LT,. Acute normovolemic hemodilution. Vox Sang 2002; 83: 211S-215S.
9. Crystal GJ, Salem MR,. Hemodynamic compensation during acute normovolemic hemodilution. Anesthesiology 2004; 100: 1034-1035. (Pubitemid 38392599)
10. Araujo LM, Garcia LV,. Acute normovolemic hemodilution: a pratical approach. Open J Anesthesiol 2013; 3: 38-43.
11. Mallett SV, Peachey TD, Sanehi O, et al. Reducing red blood cell transfusion in elective surgical patients: the role of audit and practice guidelines. Anaesthesia 2000; 55: 1013-1019.
12. Hur S, Huizenga BA, Major M,. Acute normovolemic hemodilution combined with hypotensive anesthesia and other techniques to avoid homologous transfusion in spinal fusion surgery. Spine 1992; 17: 867-873.
13. De Hert SG, Cromheecke S, Lorsomradee S, et al. Effects of moderate acute isovolaemic haemodilution on myocardial function in patients undergoing coronary surgery under volatile inhalational anaesthesia. Anaesthesia 2009; 64: 239-245.
14. Weiskopf RB, Viele MK, Feiner J, et al. Human cardiovascular and metabolic response to acute, severe isovolemic anemia. JAMA 1998; 279: 217-221. (Pubitemid 28133784)
15. Monk TG, Goodnough LT, Brecher ME, et al. A prospective randomized comparison of three blood conservation strategies for radical prostatectomy. Anesthesiology 1999; 91: 24-33. (Pubitemid 29307333)
16. Goodnough LT, Monk TG, Brecher ME,. Acute normovolemic hemodilution should replace the preoperative donation of autologous blood as a method of autologous-blood procurement. Transfusion 1998; 38: 473-476. (Pubitemid 28287505)
17. Price S, Pepper JR, Jaggar S,. Recombinant human erythropoietin use in a critically ill Jehovah's Witness after cardiac surgery. Anesth Analg 2005; 101: 325-327. (Pubitemid 41045205)
18. Kraus P, Lipman J,. Erythropoietin in a patient following multiple trauma. Anaesthesia 1992; 47: 962-964.
19. Rutherford CJ, Schneider TJ, Dempsey H, et al. Efficacy of different regimens for recombinant human erythropoietin in a stimulated perisurgical setting: the importance of iron availability in optimizing response. Am J Med 1994; 96: 139-145. (Pubitemid 24070532)
20. Kulier AH, Gombotz H, Fuchs G, et al. Subcutaneous recombinant human erythropoietin and autologous blood donation before coronary artery bypass surgery. Anesth Analg 1993; 76: 102-106. (Pubitemid 23094820)
21. Berridge MV, Fraser JK, Carter JM, et al. Effects of recombinant human erythropoietin on megacaryocytes and on platelet prodution in the rat. Blood 1988; 72: 970-977.
22. Wolf RF, Peng J, Friese P, et al. Erythropoietin administration increases production and reactivity of platelets in dogs. Thromb Haemost 1997; 78: 1505-1509. (Pubitemid 27519398)
23. Bommer J, Kugel M, Schoeppe W, et al. Dose-related effects of recombinant human erythropoietin on erythropoiesis. Contrib Nephrol 1988; 66: 85-93.
24. Naito Y, Tsujino T, Matsumoto M, et al. Adaptative response of the heart to long-term anemia induced by iron deficiency. Am J Physiol Heart Circ Physiol 2009; 296: 585-593.
25. Tircoveanu R, Van der Linden P,. Hemodilution and anemia in patients with cardiac disease: what is the safe limit? Curr Opin Anaesthesiol 2008; 21: 66-70.
26. Coursin DB, Monk TG,. Extreme normovolemic hemodilution: how low can you go and other alternatives to transfusion? Crit Care Med 2001; 29: 908-910. (Pubitemid 32299742)
27. Marik P, Corwin H,. Efficacy of red blood cell transfusion in the critically ill: a systematic review of the literature. Crit Care Med 2008; 36: 2667-2674.
28. Shander A, Javidroozi M, Ozawa S, et al. What is really dangerous: anaemia or transfusion? Br J Anaesth 2011; 107 (Suppl 1): i41-59.